Matches in SemOpenAlex for { <https://semopenalex.org/work/W2335295655> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2335295655 endingPage "949" @default.
- W2335295655 startingPage "943" @default.
- W2335295655 abstract "Colesevelam improves glycemic control in patients with type 2 diabetes when added to existing metformin-, sulfonylurea-, or insulin-based regimens. We evaluated colesevelam’s effects in subjects on stable pioglitazone-based therapy. This 24-week multicenter, double-blind, randomized, placebo-controlled study enrolled adults with type 2 diabetes who had suboptimal glycemic control [HbA1c≥58 mmol/mol (7.5%) and ≤ 80 mmol/mol (9.5%)] on pioglitazone (30 or 45 mg) with or without 1–2 other oral antidiabetes medications. Subjects were randomized to colesevelam 3.8 g/day (n=280) or placebo (n=282) added to existing pioglitazone-based therapy. Primary efficacy variable was mean change in HbA1c from baseline to Week 24. Secondary variables included safety and tolerability, fasting plasma glucose changes, glycemic responses, and lipid profile. Tertiary variables included lipid particle profile changes by nuclear magnetic resonance. Colesevelam decreased HbA1c [least-squares mean treatment difference, − 3.5 mmol/mol (− 0.32%); p<0.001] and fasting plasma glucose (− 14.7 mg/dl; p<0.001) vs. placebo at Week 24. More subjects receiving colesevelam vs. placebo achieved HbA1c reduction ≥ 7.7 mmol/mol (0.7%) (40% vs. 25%; p<0.001) or HbA1c<53 mmol/mol (7.0%) (21% vs. 13%; p=0.012). Colesevelam also decreased total cholesterol (mean treatment difference, − 6.5%), LDL-cholesterol (− 16.4%), non-HDL-cholesterol (− 9.8%), apolipoprotein B (− 8.8%), and total LDL particle concentration, and increased apolipoprotein A1 (+3.4%) and triglycerides (median treatment difference, + 11.3%) vs. placebo (all p<0.001). There were no serious drug-related adverse events, and the majority of adverse events were mild or moderate. In subjects with type 2 diabetes inadequately controlled with pioglitazone-based therapy, add-on colesevelam therapy improved glycemic control and lipid parameters and was well tolerated. <ext-link href=ClinicalTrials.gov>ClinicalTrials.gov</ext-link> identifier: NCT00789750." @default.
- W2335295655 created "2016-06-24" @default.
- W2335295655 creator A5041946210 @default.
- W2335295655 creator A5045489578 @default.
- W2335295655 creator A5048767788 @default.
- W2335295655 creator A5050055469 @default.
- W2335295655 creator A5076367660 @default.
- W2335295655 creator A5083958108 @default.
- W2335295655 date "2014-07-23" @default.
- W2335295655 modified "2023-09-27" @default.
- W2335295655 title "Efficacy and Safety of Colesevelam in Combination with Pioglitazone in Patients with Type 2 Diabetes Mellitus" @default.
- W2335295655 doi "https://doi.org/10.1055/s-0034-1383648" @default.
- W2335295655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25054436" @default.
- W2335295655 hasPublicationYear "2014" @default.
- W2335295655 type Work @default.
- W2335295655 sameAs 2335295655 @default.
- W2335295655 citedByCount "9" @default.
- W2335295655 countsByYear W23352956552015 @default.
- W2335295655 countsByYear W23352956552016 @default.
- W2335295655 countsByYear W23352956552017 @default.
- W2335295655 countsByYear W23352956552018 @default.
- W2335295655 countsByYear W23352956552021 @default.
- W2335295655 countsByYear W23352956552022 @default.
- W2335295655 crossrefType "journal-article" @default.
- W2335295655 hasAuthorship W2335295655A5041946210 @default.
- W2335295655 hasAuthorship W2335295655A5045489578 @default.
- W2335295655 hasAuthorship W2335295655A5048767788 @default.
- W2335295655 hasAuthorship W2335295655A5050055469 @default.
- W2335295655 hasAuthorship W2335295655A5076367660 @default.
- W2335295655 hasAuthorship W2335295655A5083958108 @default.
- W2335295655 hasConcept C126322002 @default.
- W2335295655 hasConcept C134018914 @default.
- W2335295655 hasConcept C142724271 @default.
- W2335295655 hasConcept C197934379 @default.
- W2335295655 hasConcept C204787440 @default.
- W2335295655 hasConcept C27081682 @default.
- W2335295655 hasConcept C2777180221 @default.
- W2335295655 hasConcept C2778163477 @default.
- W2335295655 hasConcept C2778270857 @default.
- W2335295655 hasConcept C2778375690 @default.
- W2335295655 hasConcept C2778384471 @default.
- W2335295655 hasConcept C2779306644 @default.
- W2335295655 hasConcept C2780323712 @default.
- W2335295655 hasConcept C2780473172 @default.
- W2335295655 hasConcept C555293320 @default.
- W2335295655 hasConcept C62746215 @default.
- W2335295655 hasConcept C71924100 @default.
- W2335295655 hasConcept C90924648 @default.
- W2335295655 hasConceptScore W2335295655C126322002 @default.
- W2335295655 hasConceptScore W2335295655C134018914 @default.
- W2335295655 hasConceptScore W2335295655C142724271 @default.
- W2335295655 hasConceptScore W2335295655C197934379 @default.
- W2335295655 hasConceptScore W2335295655C204787440 @default.
- W2335295655 hasConceptScore W2335295655C27081682 @default.
- W2335295655 hasConceptScore W2335295655C2777180221 @default.
- W2335295655 hasConceptScore W2335295655C2778163477 @default.
- W2335295655 hasConceptScore W2335295655C2778270857 @default.
- W2335295655 hasConceptScore W2335295655C2778375690 @default.
- W2335295655 hasConceptScore W2335295655C2778384471 @default.
- W2335295655 hasConceptScore W2335295655C2779306644 @default.
- W2335295655 hasConceptScore W2335295655C2780323712 @default.
- W2335295655 hasConceptScore W2335295655C2780473172 @default.
- W2335295655 hasConceptScore W2335295655C555293320 @default.
- W2335295655 hasConceptScore W2335295655C62746215 @default.
- W2335295655 hasConceptScore W2335295655C71924100 @default.
- W2335295655 hasConceptScore W2335295655C90924648 @default.
- W2335295655 hasIssue "13" @default.
- W2335295655 hasLocation W23352956551 @default.
- W2335295655 hasLocation W23352956552 @default.
- W2335295655 hasOpenAccess W2335295655 @default.
- W2335295655 hasPrimaryLocation W23352956551 @default.
- W2335295655 hasRelatedWork W1996010611 @default.
- W2335295655 hasRelatedWork W2031540476 @default.
- W2335295655 hasRelatedWork W2041144167 @default.
- W2335295655 hasRelatedWork W2061988825 @default.
- W2335295655 hasRelatedWork W2070740840 @default.
- W2335295655 hasRelatedWork W2124465362 @default.
- W2335295655 hasRelatedWork W2151668968 @default.
- W2335295655 hasRelatedWork W2155334925 @default.
- W2335295655 hasRelatedWork W3118157210 @default.
- W2335295655 hasRelatedWork W3142448654 @default.
- W2335295655 hasVolume "46" @default.
- W2335295655 isParatext "false" @default.
- W2335295655 isRetracted "false" @default.
- W2335295655 magId "2335295655" @default.
- W2335295655 workType "article" @default.